Dow Jones

39 112,16

-0,76%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Aesther Healthcare Acquisition Corporation (AEHA)
Aesther Healthcare Acquisition Corporation (AEHA) Actualités

AEHA

Aesther Healthcare Acqui... (AEHA)

Aesther Healthcare Acquisition Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:AEHA

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
23/06/2023	23h01	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
23/06/2023	19h59	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
23/06/2023	12h03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
15/06/2023	18h10	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
15/06/2023	12h26	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
08/06/2023	22h57	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
24/05/2023	22h39	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
16/05/2023	12h03	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
31/03/2023	23h18	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
24/03/2023	11h02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
24/02/2023	23h08	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
14/02/2023	17h28	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
13/02/2023	17h32	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
10/02/2023	17h09	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
09/02/2023	15h15	GlobeNewswire Inc.	Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce the Award of New Patents for Novel Monospecific and Bispecific Antibodies that Suppress Multiple Cancer Types	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
06/02/2023	15h15	GlobeNewswire Inc.	Aesther and Ocean Biomedical Announce Shareholder Approval of Business Combination	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
01/02/2023	23h43	GlobeNewswire Inc.	Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Measures regarding Excise Tax	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
30/01/2023	15h15	GlobeNewswire Inc.	Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce Publication of Discovery Data for a Major Anti-Tumor Pathway in Malignant Melanoma and Other Cancers	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
24/01/2023	15h15	GlobeNewswire Inc.	Ocean Biomedical Provides Corporate Update and Company Summary	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
13/01/2023	23h05	GlobeNewswire Inc.	Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Definitive Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
12/01/2023	20h06	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
30/12/2022	19h39	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
16/12/2022	14h30	GlobeNewswire Inc.	Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
13/12/2022	15h15	GlobeNewswire Inc.	Aesther Healthcare Acquisition Corp. Announces Intention to Extend Period to Consummate Business Combination	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
22/11/2022	17h33	Edgar (US Regulatory)	Proxy Statement - Merger or Acquisition (preliminary) (prem14a)	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
01/11/2022	14h15	GlobeNewswire Inc.	Novel Malaria Drug Discovery Presented at the ASTMH Tropical Medicine Meeting by Ocean Biomedical’s Scientific Co-founder, Dr. Jake Kurtis, unveiling the potential for a new class of Antimalarial Drugs.	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
05/10/2022	13h45	GlobeNewswire Inc.	Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce Execution of a Second up to $40 Million Backstop Agreement, for a Total of up to $80 Million	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
22/09/2022	13h45	GlobeNewswire Inc.	Building on Their Innovative mRNA Vaccine Program, Ocean Biomedical, Inc. and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA) Recently Announced Business Combination to Support the Discovery of a New Class of Antimalarial Drugs.	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
19/09/2022	13h45	GlobeNewswire Inc.	Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Preliminary Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc.	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation
08/09/2022	14h07	GlobeNewswire Inc.	Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce $75 Million Common Stock Purchase Transaction with White Lion Capital	NASDAQ:AEHA	Aesther Healthcare Acquisition Corporation